IMS monitors propofol plasma concentration

Status

Recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OIC-17013643

Enrollment

Unknown

Registered

2017-12-02

Start date

2017-12-06

Completion date

Unknown

Last updated

2017-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal surgery, thoracic surgery, ERCP

Interventions

Case series:Propofol by intravenous anesthesia

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Elective abdominal, thoracic, ERCP surgery; fasting 8 hours; aged 18-70 years old.

Exclusion criteria

Exclusion criteria: Body mass index (BMI)> 35, liver and kidney dysfunction, history of propofol allergy

Design outcomes

Primary

Measure	Time frame
Propofol plasma concentration;	—

Countries

China

Contacts

Public ContactDesheng Liu

The First Affiliated Hospital of Harbin Medical University

liudeshengmz@sina.com+86 15846581162

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026